Overexpression of miR-130a-3p attenuates cardiomyocyte hypertrophy.
10.7507/1001-5515.201911049
- Author:
Xiaojiao WANG
1
;
Jing QU
1
;
Dongxu LI
2
;
Junli LI
3
,
4
;
Wenchao WU
1
;
Xiaojing LIU
3
,
4
Author Information
1. Lab of Cardiovascular Diseases, Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, P.R.China.
2. Department of Cardiac Surgery, West China Hospital, Sichuan University, Chengdu 610041, P.R.China.
3. Lab of Cardiovascular Diseases, Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, P.R.China
4. Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610041, P.R.China.
- Publication Type:Journal Article
- Keywords:
Akt;
cardiomyocyte hypertrophy;
miR-130a-3p;
myocardial hypertrophy;
pressure-overload
- MeSH:
Animals;
Atrial Natriuretic Factor;
Cardiomegaly;
Mice;
MicroRNAs;
genetics;
Myocardium;
pathology;
Myocytes, Cardiac;
pathology;
Myosin Heavy Chains;
Natriuretic Peptide, Brain;
Nonmuscle Myosin Type IIB;
Proto-Oncogene Proteins c-akt;
Rats
- From:
Journal of Biomedical Engineering
2020;37(2):340-348
- CountryChina
- Language:Chinese
-
Abstract:
This study aimed to explore the role of miR-130a-3p in cardiomyocyte hypertrophy and its underlying mechanisms. Pressure-overload induced myocardial hypertrophy mice model was constructed by thoracic aortic constriction (TAC). , norepinephrine (NE) was used to stimulate neonatal rat cardiomyocytes (NRCMs) and H9c2 rat cardiomyocytes to induce hypertrophic phenotypes. The expression of miR-130a-3p was detected in mice hypertrophic myocardium, hypertrophic NRCMs and H9c2 cells. The mimics and inhibitors of miR-130a-3p were transfected into H9c2 cells to observe the role of miR-130a-3p on the hypertrophic phenotype change of cardiomyocytes separately. Furthermore, whether miR-130a-3p regulated hypertrophic related signaling pathways was explored. The results showed that the expression of miR-130a-3p was significantly decreased in hypertrophic myocardium, hypertrophic NRCMs and H9c2 cells. After transfection of miR-130a-3p mimics, the expression of hypertrophic marker genes, atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and β-myosin heavy chain (β-MHC), and the cell surface area were notably down-regulated compared with the control group (mimics N.C. + NE group). But after transfection of miR-130a-3p inhibitor, the expression of ANP, BNP and β-MHC in H9c2 cells increased significantly, and the cell area increased further. By Western blot, it was found that the protein phosphorylation level of Akt and mTOR were down-regulated after over-expression of miR-130a-3p. These results suggest that miR-130a-3p mimics may alleviate the degree of cardiomyocyte hypertrophy, meanwhile its inhibitor can further aggravate cardiomyocyte hypertrophy. Over-expression of miR-130a-3p may attenuate cardiomyocytes hypertrophy by affecting the Akt pathway.
